Aisling Capital Management LP Verona Pharma PLC Transaction History
Aisling Capital Management LP
- $273 Million
- Q4 2024
A detailed history of Aisling Capital Management LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Aisling Capital Management LP holds 1,115,352 shares of VRNA stock, worth $73.9 Million. This represents 18.98% of its overall portfolio holdings.
Number of Shares
1,115,352
Previous 1,115,352
-0.0%
Holding current value
$73.9 Million
Previous $32.1 Million
61.42%
% of portfolio
18.98%
Previous 13.2%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
219Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$424 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$370 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$224 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$208 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$207 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.04B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...